Blenman KRM, Marczyk M, Karn T, Qing T, et al. Predictive markers of response to neoadjuvant durvalumab with nab-paclitaxel and dose dense doxorubicin/cyclophosphamide in basal-like triple negative breast cancer. Clin Cancer Res 2022 Apr 4. pii: 694190. doi: 10.1158/1078-0432.CCR-21-3215.
PMID: 35377948